The two people shaping the future of OpenAI’s research

 

For the past couple of years, OpenAI has felt like a one-man brand. With his showbiz style and fundraising glitz, CEO Sam Altman overshadows all other big names on the firm’s roster. Even his bungled ouster ended with him back on top—and more famous than ever. But look past the charismatic frontman and you get a clearer sense of where this company is going. After all, Altman is not the one building the technology on which its reputation rests.

That responsibility falls to OpenAI’s twin heads of research—chief research officer Mark Chen and chief scientist Jakub Pachocki. Between them, they share the role of making sure OpenAI stays one step ahead of powerhouse rivals like Google.


I sat down with Chen and Pachocki for an exclusive conversation during a recent trip the pair made to London, where OpenAI set up its first international office in 2023. We talked about how they manage the inherent tension between research and product. We also talked about why they think coding and math are the keys to more capable all-purpose models; what they really mean when they talk about AGI; and what happened to OpenAI’s superalignment team, set up by the firm’s cofounder and former chief scientist Ilya Sutskever to prevent a hypothetical superintelligence from going rogue, which disbanded soon after he quit.

In particular, I wanted to get a sense of where their heads are at in the run-up to OpenAI’s biggest product release in months: GPT-5.

More info: Visit our page : Nomination page : https://inventionawards.org/award-nomination/?ecategory=Awards&rcategory=Awardee Registration Page: https://inventionawards.org/award-registration/ Contact us: contact@inventionawards.org

Get Connected Here:
================== Facebook : https://www.facebook.com/profile.php Twitter : https://x.com/Scitentist55046 Pinterest : https://in.pinterest.com Blogger : https://scientistsaward.blogspot.com

Comments

Post a Comment

Popular posts from this blog

Scientists Unveil World’s Smallest Molecular Machine

Image
  Researchers have successfully stabilized ferrocene molecules on a flat substrate for the first time, enabling the creation of an electronically controllable sliding molecular machine. Artificial molecular machines , composed of only a few molecules, hold transformative potential across diverse fields, including catalysis, molecular electronics, medicine, and quantum materials. These nanoscale devices function by converting external stimuli, such as electrical signals, into controlled mechanical motion at the molecular level. Ferrocene —a unique drum-shaped molecule featuring an iron (Fe) atom sandwiched between two five-membered carbon rings—is a standout candidate for molecular machinery. Its discovery, which earned the Nobel Prize in Chemistry in 1973, has positioned it as a foundational molecule in this area of study. The appeal of ferrocene lies in its remarkable property: a change in the electronic state of the Fe ion, from Fe²⁺ to Fe³⁺, induces a 36° rotation of the carbon ...
Read more

Obesity-drug pioneers win prestigious Lasker Award for medical science

Image
  Joel Habener (from left), Svetlana Mojsov and Lotte Bjerre Knudsen have won a 2024 Lasker Award for developing a class of drugs that treats obesity, diabetes and more. Three scientists involved in developing the blockbuster anti-obesity drugs that are currently changing the health-care landscape are among the winners of this year’s prestigious Lasker Awards. The prizes, which honour important advances in medical research, are often considered an indicator of whether a specific advance or scientist will win a Nobel Prize — and some are speculating that this could soon be the case for the weight-loss treatments. Joel Habener, Svetlana Mojsov and Lotte Bjerre Knudsen each contributed to the creation of the popular anti-obesity drugs, which mimic a hormone called glucagon-like peptide 1 (GLP-1), involved in lowering blood-sugar levels and controlling appetite. The trio, recognized with a Lasker in the clinical-research category, will share a US$250,000 prize. Biomedical scientists ...
Read more